Evidence map›Paper›PMID 27193292›Full record

ArticleExperimental dermatology2016

Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection.

Nathaniel B Goldstein, Maranke I Koster, Laura G Hoaglin, Michael J Wright, Steven E Robinson, William A Robinson, Dennis R Roop, David A Norris, Stanca A Birlea

Open access · greenAbstract read
In one paragraph

Article in Experimental dermatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nathaniel B GoldsteinDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Maranke I KosterDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Laura G HoaglinDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Michael J WrightDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Steven E RobinsonDepartment of Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
William A RobinsonDepartment of Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Dennis R RoopDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
David A NorrisDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Stanca A BirleaDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Stanca.Birlea@ucdenver.edu.
University of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Transgenic and Gene Targeting CoreP30AR057212 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI NORRIS, DAVID A. · 2009 to 2018
$6.2M
NCATS NIH HHS UL1 TR001082NCI NIH HHS P30 CA046934NIAMS NIH HHS P30 AR057212
6 · The paper itself

Abstract

To characterize the gene expression profile of regenerated melanocytes in the narrow band UVB (NBUVB)-treated vitiligo epidermis and their precursors in the hair follicle, we present here a strategy of RNA isolation from in situ melanocytes using human frozen skin. We developed a rapid immunostaining protocol using the NKI-beteb antibody, which labels differentiated and precursor melanocytes, followed by fluorescent laser capture microdissection. This technique enabled the direct isolation, from melanocyte and adjacent keratinocyte populations, of satisfactory quality RNA that was successfully amplified and analysed by qRT-PCR. The melanocyte-specific gene transcripts TYR, DCT, TYRP1 and PMEL were significantly upregulated in our NBUVB-treated melanocyte samples as compared with the keratinocyte samples, while keratinocyte-specific genes (KRT5 and KRT14) were expressed significantly higher in the keratinocyte samples as compared with the melanocyte samples. Furthermore, in both NBUVB-treated vitiligo skin and normal skin, when bulge melanocytes were compared with epidermal melanocytes, we found significantly lower expression of melanocyte-specific genes and significantly higher expression of three melanocytic stem cell genes (SOX9, WIF1 and SFRP1), while ALCAM and ALDH1A1 transcripts did not show significant variation. We found significantly higher expression of melanocyte-specific genes in the epidermis of NBUVB-treated vitiligo, as compared to the normal skin. When comparing bulge melanocyte samples from untreated vitiligo, NBUVB-treated vitiligo and normal skin, we did not find significant differences in the expression of melanocyte-specific genes or melanocytic stem cell genes. These techniques offer valuable opportunities to study melanocytes and their precursors in vitiligo and other pigmentation disorders.

Indexed as

Laser Capture MicrodissectionCase-Control StudiesHumansMelanocytesRNAVitiligoRNAlaser capture microdissectionmelanocytemelanocyte stem cellrepigmentationvitiligo

Identifiers

PMID27193292
PMCPMC5322465
OpenAlexW2395278323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.